Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Request for Funding for Field Based Meetings to Foster Collaborative Multi-Site Studies

BLR&D funds may be available for field based meetings. The planned meeting must address one of the following priority areas of VA research:

The planned meeting must propose to develop a plan (roadmap) for a collaborative multi-site program to accelerate the development of new treatments for service-related illness and injury. The treatments may be drugs, cell-based therapies, other biologicals or gene therapies.

The planned meeting must address an area of high importance for the health of Veterans including but not limited to:

  • Preclinical models of posttraumatic stress disorder, substance abuse, non-opioid pain treatment, suicidality, traumatic brain injury, respiratory diseases in veterans of OEF and OIF, women Veteran health issues, intergenerational effects of toxic exposures, colorectal cancer, neurodegenerative (Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis, etc.) and inflammatory brain disease (Multiple Sclerosis, etc.) and neuropsychiatric side effects of military exposures.
  • Planning meetings that address new approaches such as the use of artificial intelligence, precision medicine, genomic medicine, organoids, tissue-on-a-chip, and regenerative medicine or utilize existing VA biorepositories will be given priority.  
  • Meetings including investigators with VA biorepositories and directed at developing plans to work with samples from the biorepositories are encouraged.

The planned meeting must lead to an application for research funding (VA, NIH, or DOD). Meeting costs must be under $20,000.

The due date for applications is December 31, 2019.

Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.